Export ban and fines loom as Greek liquidity crisis reaches saturation point and first company pulls out
This article was originally published in Scrip
Executive Summary
With the news that the first drug company has buckled under pressure and decided to withdraw from the Greek market comes concern that other suppliers may follow suit. Meanwhile, existing drug shortages caused by the liquidity crisis are being exacerbated by parallel exports, according to Greek state medicines organisation EOF, which has threatened to ban such activity for certain medicines and fine companies if the problem persists.